Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Oncologists Stories

2013-12-05 12:28:53

WHITE PLAINS, N.Y., Dec. 5, 2013 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) today is pleased to announce Gregory Reaman, M.D., associate director for oncology sciences with the office of hematology and oncology products of the U.S. Food and Drug Administration (FDA), will be presented with the prestigious Return of the Child Award at a reception at the New Orleans Marriott on December 6, 2013. The Return of the Child Award honors an individual who has made a major and...

2013-11-12 16:25:35

CHICAGO, Nov. 12, 2013 /PRNewswire/ -- LUGPA, an organization advocating for integrated and coordinated urological care with more than 2,000 member physicians across the U.S., announces Juan A. Reyna, MD, a urologist practicing in San Antonio, is the new president of the Board of Directors. Reyna was installed in the position during the LUGPA annual membership meeting in Chicago. (Logo: http://photos.prnewswire.com/prnh/20131024/FL03745LOGO) "As a founding member of LUGPA, I've...

2013-11-04 23:19:57

Top-Flight Gynecologic Oncology Team to Direct Mount Sinai Program New York, NY (PRWEB) November 04, 2013 Peter R. Dottino, MD, has been appointed Director of the Division of Gynecologic Oncology in the Department of Obstetrics, Gynecology and Reproductive Medicine at the Mount Sinai Health System, effective October 1, 2013. He also holds an appointment as Associate Clinical Professor at the Icahn School of Medicine at Mount Sinai. Dr. Dottino is an internationally-renowned expert in...

2013-10-17 12:29:35

Ocean Medical Center is first hospital in Monmouth and Ocean Counties to offer Xofigo treatment. BRICK, N.J., Oct. 17, 2013 /PRNewswire-USNewswire/ -- Men who have been diagnosed with advanced prostate cancer now have a new treatment option at Ocean Medical Center. Recently approved by the FDA, Xofigo is an intravenous (IV) injection of a radioactive material that treats metastatic prostate cancer resistant to medical or surgical treatments. If prostate cancer grows outside of the...

2013-10-15 08:33:04

BUFFALO, N.Y., Oct. 15, 2013 /PRNewswire/ -- Kinex Pharmaceuticals, a leading specialty biotech focused on the development and commercialization of next generation oral therapies for cancer and immunomodulatory diseases is pleased to welcome Dr. Daniel Von Hoff, MD, F.A.C.P., as Chair of its Clinical Advisory Committee. Dr. Von Hoff is highly regarded as a medical oncologist and drug developer by his colleagues worldwide. As the current Physician-in-Chief at the Translational...

2013-10-14 04:21:29

SEATTLE, Oct. 14, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) today announced the addition of three leaders in the research and development of new treatments for blood-related cancers to CTI's recently formed Scientific Advisory Board (SAB): Alan List, M.D., President and CEO of Moffitt Cancer Center; Ross Levine, M.D., Associate Attending Physician at Memorial Sloan-Kettering Cancer Center; and Brian Druker, M.D., Director of the Knight Cancer...

2013-10-11 08:23:53

WALTHAM, Mass., Oct. 11, 2013 /PRNewswire/ -- Syndax Pharmaceuticals Inc. today announced the appointment of Steven M. Fruchtman, M.D., a hematologist/oncologist with extensive experience in early and late-stage drug development with biopharmaceutical companies and in clinical practice, as chief medical officer. Dr. Fruchtman will oversee clinical development programs for entinostat in breast, lung and other malignancies. This will include the company's work with ECOG-ACRIN Cancer...

2013-10-10 23:26:49

prIME Oncology, an independent medical education company, is pleased to announce that Karen Overstreet, EdD, RPh, FACEHP, CCMEP, has joined the organization as Senior Director, Educational Strategy and Outcomes. Atlanta, Georgia (PRWEB) October 10, 2013 prIME Oncology, a leading provider of continuing medical education (CME) for oncologists around the world, is pleased to announce that Karen Overstreet, EdD, RPh, FACEHP, CCMEP, has joined the organization as Senior Director, Educational...

2013-10-09 23:03:40

Charles J. Sherr, M.D., Ph.D., to receive the Prize for Scientific Excellence in Medicine by the American-Italian Cancer Foundation Memphis, Tenn. (PRWEB) October 09, 2013 Charles J. Sherr, M.D., Ph.D., chair of the St. Jude Children’s Research Hospital Department of Tumor Cell Biology and a Howard Hughes Medical Institute Investigator, has been selected to receive the 2013 Prize for Scientific Excellence in Medicine by the American-Italian Cancer Foundation. The Prize for Scientific...

2013-10-09 23:01:44

Registration is now open for the Society for Translational Oncology (STO) 2013 Chabner Colloquium: Collaboration in Cancer Trials. The meeting will be held October 28-29, 2013 at the Starr Center at Schepens Eye Research Institute in Boston, Massachusetts. Durham, NC (PRWEB) October 09, 2013 Registration is now open for the Society for Translational Oncology (STO) 2013 Chabner Colloquium: Collaboration in Cancer Trials. The continuing medical education (CME) symposium is jointly sponsored...